Perrigo

PRGO

Market cap $1.82B

Perrigo misses Q4 EPS estimates. Its 2026 sales and profit estimates are below expectations as Infant Formula headwinds persist.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Perrigo Company plc (PRGO) Q4 2025 Earnings Call Transcript

While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Perrigo (PRGO) came out with quarterly earnings of $0.77 per share, missing the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.93 per share a year ago.

Delivered FY2025 Adj. EPS at the Midpoint of Updated Outlook Range Advanced '3-S Plan' with Perrigo Store Brand OTC and Key Brands Gaining Share 1,2 in 2025, Despite Soft Category Consumption Launching New Operational Enhancement Program - Expected to Deliver Pre-Tax Annualized Savings of $80 million to $100 million Transitioning to New Reporting Segments Beginning Q1 2026, Aligned to Commercial Operating Model Issues FY2026 'All In' Outlook; Introduces FY2026 'CORE' Outlook, which Excludes Infant Formula and Previously Announced Divestitures Fourth Quarter 2025 YoY Highlights : Net Sales: $1.11 billion, -2.5% year-over-year as favorable FX +2.3% was more than offset by organic net sales -4.5% and the impact of divestitures and exited products -0.4%.

Get a deeper insight into the potential performance of Perrigo (PRGO) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

The average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in Perrigo (PRGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Investors aren't putting cash under their mattresses, but they're certainly looking to take some risk off the table. This means rotation out of high-growth technology stocks and looking for value.

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.